Apogee Therapeutics Funding: $169M Raised, Series B (2022)

Apogee Therapeutics funding overview

Apogee Therapeutics is based in Waltham, MA. Apogee Therapeutics has raised $169M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in December 2022. The round record for Apogee Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Deep Track Capital, RTW Investments, LP, Fidelity Management & Research Company, OrbiMed, Perceptive Xontogeny Ventures Fund II, RA Capital Management and 3 others. 9 distinct backers are named across the disclosed rounds.

Apogee Therapeutics at a glance

Total raised: $169M
Latest round: Series B
Latest round date: December 2022
Headquarters: Waltham, MA
Notable investors: Deep Track Capital, RTW Investments, LP, Fidelity Management & Research Company, OrbiMed, Perceptive Xontogeny Ventures Fund II, RA Capital Management, Wellington Management, Fairmount

Frequently asked about Apogee Therapeutics funding

How much has Apogee Therapeutics raised?: Apogee Therapeutics has raised $169M in total disclosed funding across the rounds on record.
Who has invested in Apogee Therapeutics?: Deep Track Capital, RTW Investments, LP, Fidelity Management & Research Company, OrbiMed, Perceptive Xontogeny Ventures Fund II, RA Capital Management are named among the investors backing Apogee Therapeutics.
What was the latest Apogee Therapeutics funding round?: The most recent disclosed round is a Series B, announced in December 2022.
Where is Apogee Therapeutics based?: Apogee Therapeutics is based in Waltham, MA.
When did Apogee Therapeutics last raise?: The last disclosed Apogee Therapeutics round closed in December 2022 at Series B.

Apogee Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Waltham below to benchmark round size and investor mix.

Apogee Therapeutics Funding: $169M Raised, Series B (2022)

Apogee Therapeutics funding overview

Apogee Therapeutics at a glance

Frequently asked about Apogee Therapeutics funding

Companies related to Apogee Therapeutics (36)

Browse related funding lists (6)